Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut metagenome

ABSTRACT: Study of Intestinal microbiota in graft-versus-host disease

PROVIDER: PRJDB4167 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR067308_1.fastq.gz	Fastqsanger.gz
	DRR067308_2.fastq.gz	Fastqsanger.gz
	DRR067309_1.fastq.gz	Fastqsanger.gz
	DRR067309_2.fastq.gz	Fastqsanger.gz
	DRR067310_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 192

Similar Datasets

mouse gut metagenome

Project description:Study of Intestinal microbiota in graft-versus-host disease

| PRJDB4167 | ENA

mouse gut metagenome (410661)

Project description:Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity

| PRJNA980199 | ENA

mouse gut metagenome

Project description:Impacts of Intestinal microbiota on graft-versus-host disease and engraftment after hematopoietic stem cell transplant

| PRJDB5102 | ENA

gut metagenome

Project description:Fecal microbiota transplantations reconstitute gut fungal and viral microbiota in graft-versus-host disease

| PRJNA515137 | ENA

gut metagenome

Project description:Metagenomic next-generation sequencing of Graft-versus-Host disease

| PRJNA396964 | ENA

human gut metagenome

Project description:Fecal microbiota transplantation for the gastrointestinal steroid-refractory graft-versus host disease using frozen capsule.

| PRJDB7070 | ENA

Project description:Bacteroides ovatus alleviates dysbiotic microbiota induced intestinal graft-versus-host disease

| PRJNA973955 | ENA

Project description:Intestinal Microbiota Controls Graft-versus-Host Disease Independent of Donor-Host Genetic Disparity

| PRJNA979931 | ENA

The effect of LCN2 treatment on anti-inflammatory bone marrow derived macrophages

Project description:Allogeneic hematopoietic stem cell transplantation remains the most efficacious treatment for many hematological malignancies. However, its therapeutic potential is affected by the most prominent side effect graft versus host disease. Despite advances in the treatment of graft versus host disease in recent years, morbidity and mortality remains high, which requires the development of new treatment approaches. We therefore implemented mouse models to assess potential treatment options for graft versus host disease. In in vivo experiments, we had observed a protective effect of LCN2 on graft versus host disease of the gastrointestinal tract. We also observed higher numbers of anti-inflammatory macrophages in the intestinal tissues of these animals. Therefore, we aimed to determine potentially regulated genes in these cells by using an in vitro approach of LCN2-treated macrophages.

2024-01-24 | GSE226432 | GEO

Relating human gut metagenome and metaproteome

Project description:Gut microbiome research is rapidly moving towards the functional characterization of the microbiota by means of shotgun meta-omics. Here, we selected a cohort of healthy subjects from an indigenous and monitored Sardinian population to analyze their gut microbiota using both shotgun metagenomics and shotgun metaproteomics. We found a considerable divergence between genetic potential and functional activity of the human healthy gut microbiota, in spite of a quite comparable taxonomic structure revealed by the two approaches. Investigation of inter-individual variability of taxonomic features revealed Bacteroides and Akkermansia as remarkably conserved and variable in abundance within the population, respectively. Firmicutes-driven butyrogenesis (mainly due to Faecalibacterium spp.) was shown to be the functional activity with the higher expression rate and the lower inter-individual variability in the study cohort, highlighting the key importance of the biosynthesis of this microbial by-product for the gut homeostasis. The taxon-specific contribution to functional activities and metabolic tasks was also examined, giving insights into the peculiar role of several gut microbiota members in carbohydrate metabolism (including polysaccharide degradation, glycan transport, glycolysis and short-chain fatty acid production). In conclusion, our results provide useful indications regarding the main functions actively exerted by the gut microbiota members of a healthy human cohort, and support metaproteomics as a valuable approach to investigate the functional role of the gut microbiota in health and disease.

2017-07-19 | PXD005780 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data